Purple Biotech
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -47 | -45 | -40 | -49 |
EBITDA | -1,042 | -376 | -886 | -108 |
EBIT | -1,089 | -421 | -926 | -157 |
Net Income | -1,085 | -453 | -410 | -663 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -1,546 | -1,978 | -2,014 | -3,295 |
Cash | 4,736 | 5,772 | 7,401 | 5,438 |
Basic Shares | 13 | 13 | 2,585 | 1,739 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $195 | $-910 | $-320 |
Gross Profit | -186 | |||
EBITDA | -7,052 | -22,225 | -21,492 | -17,516 |
EBIT | -7,238 | -22,271 | -21,693 | -17,747 |
Net Income | -7,240 | -19 | -21,668 | -18,384 |
Net Change In Cash | 0 | 195 | -910 | -320 |
Free Cash Flow | -14,367 | -19,928 | -16,963 | -15,186 |
Cash | 7,401 | 14,489 | 15,030 | 10,890 |
Basic Shares | 2,585 | 1,230 | 924 | 890 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.40 |
2025-03-31 | -$0.17 |
2024-12-31 | -$0.27 |
2024-09-30 | -$1.37 |
